KPDA gives notice of high-intensity responses to unfair pharmaceutical agreements
The Korea Pharmaceutical Distribution Association(KPDA) has given a notice of high-intensity responses to unfair agreements on a basis of its member companies’ reports.
The KPDA has pointed out agreements between pharmaceutical and distribution companies have frequently made with unfair terms an...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
